Fig. 6

Prediction of potential therapeutic agents. A Workflow of drug prediction and analysis using online tools. B Rank plots showing the results of drug prediction in BD, SCL, and VKH, the top 10 drugs in sEVs, lEVs, and plasma were listed in the plots, and approved drugs for clinical use are in gray background. C Drug-protein-disease interactions were obtained through the CTD, the red arrows represent upregulated protein expression while the blue arrows represent downregulated protein expression. BD Behcet's disease uveitis, SCL posterior scleritis, VKH Vogt-Koyanagi-Harada syndrome